Review Article | Open Access
Yan-Xi Zhou, Hai-Liang Xin, Khalid Rahman, Su-Juan Wang, Cheng Peng, Hong Zhang, "Portulaca oleracea L.: A Review of Phytochemistry and Pharmacological Effects", BioMed Research International, vol. 2015, Article ID 925631, 11 pages, 2015. https://doi.org/10.1155/2015/925631
Portulaca oleracea L.: A Review of Phytochemistry and Pharmacological Effects
Portulaca oleracea L., belonging to the Portulacaceae family, is commonly known as purslane in English and Ma-Chi-Xian in Chinese. It is a warm-climate, herbaceous succulent annual plant with a cosmopolitan distribution. It is eaten extensively as a potherb and added in soups and salads around the Mediterranean and tropical Asian countries and has been used as a folk medicine in many countries. Diverse compounds have been isolated from Portulaca oleracea, such as flavonoids, alkaloids, polysaccharides, fatty acids, terpenoids, sterols, proteins vitamins and minerals. Portulaca oleracea possesses a wide spectrum of pharmacological properties such as neuroprotective, antimicrobial, antidiabetic, antioxidant, anti-inflammatory, antiulcerogenic, and anticancer activities. However, few molecular mechanisms of action are known. This review provides a summary of phytochemistry and pharmacological effects of this plant.
Portulaca oleracea L. is a warm-climate, herbaceous succulent annual plant with a cosmopolitan distribution belonging to the Portulacaceae family. It is commonly known as purslane (USA and Australia), rigla (Egypt), pigweed (England), pourpier (France), and Ma-Chi-Xian (China) . It is distributed widely in the tropical and subtropical areas of the world including many parts of the United States and is eaten extensively as a potherb and is added to soups and salads around the Mediterranean and tropical Asian countries . Americans and aborigines of Australia grind the seeds of this plant into flour for use in mush and bread . Portulaca oleracea also provides a source of nutritional benefits owing to its rich omega-3 fatty acids and antioxidant properties .
Portulaca oleracea has been used as a folk medicine in many countries, acting as a febrifuge, antiseptic, vermifuge, and so forth . It exhibits a wide range of pharmacological effects, including antibacterial , antiulcerogenic , anti-inflammatory , antioxidant , and wound-healing  properties. It is listed by the World Health Organization as one of the most used medicinal plants, and it has been given the term “Global Panacea” . The Chinese folklore described it as “vegetable for long life” and it has been used for thousands of years in traditional Chinese Medicine [12, 13]. It is cold in nature and sour in taste and is used to cool the blood, stanch bleeding, clear heat, and resolve toxins. The dried aerial part of this plant is indicated for the treatment of fever, dysentery, diarrhoea, carbuncle, eczema and hematochezia, with a recommended dose of 9–15 g [14–16].
Portulaca oleracea has a high potential to be used as human and animal food and to be utilized as a pharmacological agent in medicine. In this paper, phytochemistry and pharmacological activities of this plant are reviewed and its potential for further investigation, exploitation, and utilization are discussed.
Many constituents of Portulaca oleracea have been isolated, including flavonoids, alkaloids, fatty acids, terpenoids, polysaccharides, vitamins, sterols, proteins, and minerals; these are listed in Table 1 and the chemical structures of the main compounds are presented in Figure 1.
One of the most effective constituents present in Chinese Herbal Medicines are flavonoids which are biologically active and possess a wide range of pharmacological properties such as antibacterial, antivirus, anti-inflammation, and antioxidation properties. In the Portulaca oleracea plant, the flavonoids levels vary according to the part of the plant; the highest levels are present in the root followed by stem and the leaf; and seven different flavonoids are present in this plant, including kaempferol, myricetin, luteolin, apigenin, quercetin, genistein, and genistin . However, only kaempferol and apigenin have been found in ethanolic extracts of leaves and stems, with the levels in the former being higher . Portulacanones B–D, three homoisoflavonoids compounds, display selectively cytotoxic activities against three human cancer cell lines (SF-268, NCI-H460, and SGC-7901) . Flavonoids are also widely present in foods such as fruits and vegetables .
In addition to flavonoids, another important chemical found in this plant is alkaloids including dopa, dopamine, and noradrenalin. The content of dopamine and noradrenalin is higher in leaves compared to stem and seeds. The amount of dopamine and noradrenalin obtained from leaves varies according to the solvents used in the extraction process, suggesting that the levels of these compounds are dependent on the solvents used during the extraction process . Oleraceins A, B, C, D, and E are cyclodopa alkaloids isolated from this plant  and several analytes such as (3R)-3,5-bis(3-methoxy-4-hydroxyphenyl)-2,3-dihydro-2(1H)-pyridinone and 1,5-dimethyl-6-phenyl-1,2-dihydro-1,2,4-triazin-3(2H)-one display cytotoxic activities against human cancer cells .
Portulaca oleracea is also an excellent source of omega-3 fatty acids, which is usually present in oil and fat of fishes but not normally found in plants. Omega-3 fatty acids play an important role in the enhancement of immune function  and prevention and treatment of hypertension, coronary artery disease, cancer, and other inflammatory and autoimmune disorders . It includes α-linolenic acid and linoleic acid, which are essential for normal growth, health promotion, and disease prevention in humans. Polysaccharides found in Portulaca oleracea are potential therapeutic agents for the treatment of diabetes mellitus owing to their modulation of blood lipids, metabolism, and decrease of blood glucose. Portulaca oleracea contains monoterpenes such as portulosides A and B, diterpenes such as portulene, and β-amyrin type triterpenoids [1, 25]; in addition, vitamins have also been isolated from the leaves of this plant. It contains the highest content of vitamin A which is a natural antioxidant playing an important role in vision, maintaining healthy mucus membranes and protecting against lung and oral cavity cancers among green leafy vegetables. This plant also contains ascorbic acid, α-tocopherol, and B-complex vitamins, for example, niacin, pyridoxine, and riboflavin . Furthermore it is rich in minerals like phosphorus, manganese, icon, calcium selenium , and the amino acids isoleucine, proline, leucine, lysine, phenylalanine, methionine, cystine, valine, threonine, and tyrosine . Many other constituents have also been isolated from this plant, such as β-carotene, glutathione, melatonin, portulacerebroside A, catechol, and bergapten.
Over the past decades, numerous researchers have investigated the pharmacological activities of Portulaca oleracea. This review provides a comprehensive summary of the main pharmacological properties which are presented below.
3.1. Neuroprotective Activity
Administration of Portulaca oleracea can scavenge free radicals and antagonize rotenone-induced neurons apoptosis, dopamine depletion, and complex-I inhibition in striatum of rats, suggesting that Portulaca oleracea may be a potential neuroprotective candidate against Parkinson’s disease . The extract of Portulaca oleracea (EP) protects nerve tissue/cells from hypoxic damage probably by elevation of glycolysis, EPO, and hypoxia inducible factor-1 expression levels . The ethanol extract decreases the activity of caspase-3 in neuron whilst reducing serum levels of neuron specific enolase in hypoxia mice and the pathological damages caused by hypoxia. In these studies, an increase in the neuron viability and an induction in the mRNA and protein expression of endogenous erythropoietin have also been reported. Thus, the stabilization of hypoxia inducible factor-1 α expression is associated with the neuroprotective effects of EP against hypoxia injury by eliciting endogenous erythropoietin expression . β-Cyanin evidently inhibits D-galactose-induced neurotoxicity in mice, which at the doses of 50 and 100 mg/kg upregulates the activities of superoxide dismutases, catalase, glutathione reductase, and glutathione peroxidase, whilst reducing the level of the lipid peroxidation product malondialdehyde in the brain of D-galactose-treated mice. When compared to vitamin C, β-cyanin play a more pronounced effect on alleviating cognition deficits in mice . The total alkaloidal extracts from 31 traditional Chinese Herbal Medicines were tested for their acetylcholinesterase (AChE) inhibitory activities by Ellman’s method and modified TLC bioautographic assay. As a result, the alkaloidal extract of Portulaca oleracea significantly inhibited AChE activity at a final concentration of 100 μg/mL with the IC50 value of 29.4 μg/mL. The use of AChE inhibitors has been a promising treatment strategy for Alzheimer’s disease (AD); therefore, Portulaca oleracea may be an effective agent for the prophylaxis and treatment of AD .
3.2. Antidiabetic Activity
Portulaca oleracea attenuates body weight, serum free fatty acids, and hyperinsulinemia. It also increases insulin sensitivity and ameliorates impaired glucose tolerance and lipid metabolism in rats with type 2 diabetes mellitus induced by injection of streptozotocin (25 mg/kg) and feeding of high calorie forage, suggesting that Portulaca oleracea alleviates insulin resistance . Administration of the seeds powder (5 g × 2/day) increases high density lipoprotein cholesterol (HDLC) and albumin, while lowering the levels of serum total cholesterol, triglycerides, low density lipoprotein cholesterol (LDLC), liver gamma glutamyl transaminase (GGT), alanine transaminase (ALT), aspartate transaminase (AST), total and direct bilirubin, fasting and postprandial blood glucose, insulin, body weight, and body mass index in type 2 diabetic subjects. There were no differences in these results compared to the data obtained with metformin treatment (1500 mg/day) except for LDLC, HDLC, and alkaline phosphatase (ALP) levels, suggesting that Portulaca oleracea seeds are valuable and effective as an adjunctive and alternative therapy for the treatment of type 2 diabetes mellitus .
The aqueous extract of Portulaca oleracea also prevents diabetic vascular inflammation, hyperglycemia, and diabetic endothelial dysfunction in type 2 diabetic db/db mice, suggesting its protective role against diabetes and related vascular complications . The crude polysaccharide extract of this plant also lowers blood glucose and modulates the metabolism of blood lipids and glucose in alloxan-induced diabetic mice , whilst decreasing the levels of total cholesterol, triglycerides, and fasting blood glucose in type 2 diabetic mice .
3.3. Antioxidant Activity
The antioxidant property of Portulaca oleracea is attributed to its constituents, such as gallotannins, omega-3 fatty acids, ascorbic acid, α-tocopherols, kaempferol, quercetin, and apigenin [8, 16, 17]. The single cell gel electrophoresis assay (comet assay), which is an simple, rapid, and inexpensive method for measuring DNA strand breaks, confirmed that the aqueous extract significantly alleviated hydrogen peroxide-induced oxidative DNA lesions in human lymphocytes, whereas the ethanolic extract had no effects, which may be associated with the antioxidant constituents contained in the aqueous extract . The aqueous extract decreases high fat diet-elicited oxidative damage by modulating blood and liver antioxidant enzyme activities, elevating leptin/β-actin and liver PPAR a/β-actin and inhibiting the protein expression of p-PERK and the FAS mRNA expression of liver and spleen in mice . In another study, the aqueous extract at a concentration range of 100, 150, 200, and 400 μg/mL and the ethanolic extract at a range of 1200 and 1800 μg/mL, respectively, exerted cytoprotective effects on 2,2′-azobis hydrochloride-induced hemolytic damages of RBCs in a concentration-dependent manner .
3.4. Anticancer Activity
Polysaccharides from Portulaca oleracea display several biological activities, such as anticancer, antioxidation, anti-inflammation, and immunity enhancing properties [37–40]. Polysaccharides evidently scavenge the accumulation of free radicals and modulate immunity functions of rats with ovarian cancer . Sulfated derivatives of POP, a water-soluble polysaccharide isolated from Portulaca oleracea, have a suppressive effect on the growth of HeLa and HepG2 cells in vitro, suggesting that the sulfation of POP increases the cytotoxicity in tumor cells . In addition to polysaccharides, other bioactive compounds such as cerebrosides, homoisoflavonoids, and alkaloids also show in vitro cytotoxic activities against human cancer cell lines. Portulacerebroside A stimulates human liver cancer HCCLM3 cell apoptosis via the activation of the p38 MAPK- and JNK-triggered mitochondrial death pathway  and 2,2′-dihydroxy-4′,6′-dimethoxychalcone is more active against cell line SGC-7901 with an IC50 value of 1.6 ug/mL than mitomycin C which has an IC50 value of 13.0 ug/mL. Portulacanones B is active against SGC-7901 cell lines with an IC50 value of 16.2 ug/mL, which is very close to the value obtained with mitomycin C. 2,2′-Dihydroxy-4′,6′-dimethoxychalcone is moderately active against K-562 cells with an IC50 value of 24.6 ug/mL and portulacanones B–D show selective cytotoxic activity against SF-268 and/or NCI-H460 cells with IC50 values of 14.3–20.1 ug/mL . N-trans-Feruloyltyramine, (7′R)-N-feruloylnormetanephrine, 1,5-dimethyl-6-phenyl-1,2-dihydro-1,2,4-triazin-3(2H)-one, and (3R)-3,5-bis(3-methoxy-4-hydroxyphenyl)-2,3-dihydro-2(1H)-pyridinone have weak bioactivities against K562 with IC50 values of 222.77, 66.94, 90.09, and 41.52 umol/L, respectively, and moderate bioactivities against A549 with IC50 values of 28.80, 21.76, 24.54, and 37.20 umol/L, respectively . These studies demonstrate that Portulaca oleracea has a potential application in the treatment of cancer.
Portulaca oleracea possesses antibacterial, antifungal, and antiviral activities as revealed by its antifungal effect against dermatophytes of the genera Trichophyton . A pectic polysaccharide isolated from the aerial part of this plant displays antiherpes property against simplex virus type 2 which is due to the inhibition of virus penetration and not virus adsorption . A 70% methyl alcohol extract of Portulaca oleracea shows antibacterial activity against the Gram-negative stains: Escherichia coli, Pseudomonas aeruginosa, and Neisseria gonorrhea with inhibition zones of 14, 15, and 15 mm, respectively, and the Gram-positive strains: Staphylococcus aureus, Bacillus subtilis, and Streptococcus faecalis with inhibition zones of 13, 14, and 15 mm, respectively, as well as antifungal activity against Candida albicans with inhibition zone of 12 mm .
3.6. Anti-Inflammatory Activity
Pretreatment with the aqueous extract of Portulaca oleracea inhibits tumor necrosis factor- (TNF-) α-induced production of intracellular reactive oxygen species (ROS) and overexpression of intercellular adhesion molecule- (ICAM-) 1, vascular cell adhesion molecule (VCAM)-1, and E-selectin in human umbilical vein endothelial cells (HUVECs) in a dose-dependent manner. This extract also suppresses the translocation of nuclear factor κB (NF-κB) p65 to the nucleus, TNF-α-induced NF-κB binding, and the degradation of inhibitor molecule (IκB)α. Furthermore, an inhibition in the adhesion of HL-60 cells to TNF-α-induced HUVECs and TNF-α-induced mRNA expression of interleukin- (IL-) 8 and monocyte chemoattractant protein- (MCP-) 1 is also observed. The aqueous extract of Portulaca oleracea may also play an important role in the suppression of the vascular inflammatory process related to the development of atherosclerosis .
3.7. Antiulcerogenic Activity
Aqueous and ethanolic extracts of Portulaca oleracea at 0.8 g/kg and 1.4 g/kg, respectively, can reduce the severity of HCl-induced gastric ulcers in a dose-dependent manner; this is comparable to the effect observed with sucralfate 0.1 g/kg. In addition, the aqueous extract (0.56 and 0.8 g/kg) and the ethanolic extract (0.8 and 1.4 g/kg) display suppression of lesions induced by absolute ethanol. The oral and intraperitoneal doses of both extracts dose-dependently increase the pH of gastric juice in mice with pylorus ligation. Thus, Portulaca oleracea holds great promise as an effective therapeutic agent for gastrointestinal diseases due to its gastroprotective activity .
3.8. Hepatoprotective Activity
Intraperitoneal administration of CCl4 elicits liver injury in rats, which notably upregulates the levels of total bilirubin and serum hepatic marker enzymes, including glutamate pyruvate transaminase (GPT) and glutamate oxaloacetate transaminase (GOT). A 70% alcohol extract of Portulaca oleracea significantly reverses the increase in hepatic marker enzymes and total bilirubin levels, confirming the hepatoprotective activity of this plant .
3.9. Other Activities
The ethanol extract from Portulaca oleracea at a concentration range of 100, 200, and 400 mg/kg, respectively, displays a dose-dependent effect in prolonging the survival time of mice in hypoxic models, including closed normobaric hypoxia and potassium cyanide or sodium nitrite toxicosis. This extract also enhances the activities of phosphofructokinase, pyruvate kinase, and lactate dehydrogenase in glycolysis and the level of adenosine triphosphate of mouse cortices in hypoxia models . The preliminary wound healing activity of Portulaca oleracea has been appraised in Mus musculus JVI-1 and it has been shown that a fresh crude extract significantly accelerates the wound healing course by the stimulation of wound contraction and downregulation of the surface area of the excision wound . Portulaca oleracea also has the ability to accumulate Se even at the shortest time span of 42 days, and hence it can perform the dual functions of preventing the occurrence of Se deficiency linked diseases such as Keshan and Kashin-Beck diseases .
Portulaca oleracea is of considerable importance to the food industry and also possesses a wide spectrum of pharmacological properties such as neuroprotective, antimicrobial, antidiabetic, antioxidant, anti-inflammatory, antiulcerogenic, and anticancer activities, which are associated with its diverse chemical constituents, including flavonoids, alkaloids, polysaccharides, fatty acids, terpenoids, sterols, proteins, vitamins, and minerals.
Although bioactivities of extracts or compounds isolated from Portulaca oleracea are substantiated by using in vitro and in vivo studies including animal models and cell culture studies, the mechanisms of action have not been addressed. Hence, more mechanistic studies are required before Portulaca oleracea can be considered for further clinical use. This review concludes that Portulaca oleracea is an edible and a medicinal plant which is important to the food industry and may also have a significant role to play in health care provided that adequate studies are conducted.
Conflict of Interests
The authors have declared that there is no conflict of interests.
Yan-Xi Zhou and Hai-Liang Xin contributed equally to this work.
This work was supported by the National Natural Science Foundation of China (nos. 81173462 and 81102774), National Science and Technology Major Projects for Major New Drugs Innovation and Development (2014ZX09J14106-06c), and the Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources.
- E. S. Elkhayat, S. R. M. Ibrahim, and M. A. Aziz, “Portulene, a new diterpene from Portulaca oleracea L.,” Journal of Asian Natural Products Research, vol. 10, no. 11-12, pp. 1039–1043, 2008.
- U. R. Palaniswamy, B. B. Bible, and R. J. McAvoy, “Effect of nitrate: ammonium nitrogen ratio on oxalate levels of purslane,” Trends in New Crops and New Uses, vol. 11, no. 5, pp. 453–455, 2002.
- A. I. Mohamed and A. S. Hussein, “Chemical composition of purslane (Portulaca oleracea),” Plant Foods for Human Nutrition, vol. 45, no. 1, pp. 1–9, 1994.
- U. R. Palaniswamy, R. J. McAvoy, and B. B. Bible, “Stage of harvest and polyunsaturated essential fatty acid concentrations in purslane (Portulaca oleraceae) leaves,” Journal of Agricultural and Food Chemistry, vol. 49, no. 7, pp. 3490–3493, 2001.
- A. S. Lee, J. S. Kim, Y. J. Lee, D. G. Kang, and H. S. Lee, “Anti-TNF-α activity of Portulaca oleracea in vascular endothelial cells,” International Journal of Molecular Sciences, vol. 13, no. 5, pp. 5628–5644, 2012.
- X. J. Zhang, Y. B. Ji, Z. Y. Qu, J. C. Xia, and L. Wang, “Experimental studies on antibiotic functions of Portulaca oleracea L. in vitro,” Chinese Journal of Microecololgy, vol. 14, no. 6, pp. 277–280, 2002.
- G. Karimi, H. Hosseinzadeh, and N. Ettehad, “Evaluation of the gastric antiulcerogenic effects of Portulaca oleracea L. extracts in mice,” Phytotherapy Research, vol. 18, no. 6, pp. 484–487, 2004.
- K. Chan, M. W. Islam, M. Kamil et al., “The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) Celak,” Journal of Ethnopharmacology, vol. 73, no. 3, pp. 445–451, 2000.
- B. Chen, H. Zhou, W. Zhao, W. Zhou, Q. Yuan, and G. Yang, “Effects of aqueous extract of Portulaca oleracea L. on oxidative stress and liver, spleen leptin, PARα and FAS mRNA expression in high-fat diet induced mice,” Molecular Biology Reports, vol. 39, no. 8, pp. 7981–7988, 2012.
- A. N. Rashed, F. U. Afifi, and A. M. Disi, “Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1,” Journal of Ethnopharmacology, vol. 88, no. 2-3, pp. 131–136, 2003.
- X. Xu, L. Yu, and G. Chen, “Determination of flavonoids in Portulaca oleracea L. by capillary electrophoresis with electrochemical detection,” Journal of Pharmaceutical and Biomedical Analysis, vol. 41, no. 2, pp. 493–499, 2006.
- C.-J. Chen, W.-Y. Wang, X.-L. Wang et al., “Anti-hypoxic activity of the ethanol extract from Portulaca oleracea in mice,” Journal of Ethnopharmacology, vol. 124, no. 2, pp. 246–250, 2009.
- R. Jin, Z. J. Lin, C. M. Xue, and B. Zhang, “An improved association-mining research for exploring Chinese herbal property theory: based on data of the Shennong's Classic of Materia Medica,” Journal of integrative medicine, vol. 11, no. 5, pp. 352–365, 2013.
- J. Li, X.-L. Wu, Y. Chen et al., “Antidiarrheal properties of different extracts of Chinese herbal medicine formula Bao-Xie-Ning,” Journal of Chinese Integrative Medicine, vol. 11, no. 2, pp. 125–134, 2013.
- C. Q. Zhao, Y. Zhou, J. Ping, and L. M. Xu, “Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities,” Journal of Integrative Medicine, vol. 12, no. 5, pp. 401–408, 2014.
- Committee for the Pharmacopoeia of PR China, Pharmacopoeia of PR China: Part I, China Medical Science and Technology Press, Beijing, China, 2010.
- H. B. Zhu, Y. Z. Wang, Y. X. Liu, Y. l. Xia, and T. Tang, “Analysis of flavonoids in Portulaca oleracea L. by UV-vis spectrophotometry with comparative study on different extraction technologies,” Food Analytical Methods, vol. 3, no. 2, pp. 90–97, 2010.
- J. Yan, L.-R. Sun, Z.-Y. Zhou et al., “Homoisoflavonoids from the medicinal plant Portulaca oleracea,” Phytochemistry, vol. 80, pp. 37–41, 2012.
- M. Nassiri-Asl, T. Naserpour Farivar, E. Abbasi et al., “Effects of rutin on oxidative stress in mice with kainic acid-induced seizure,” Journal of Integrative Medicine, vol. 11, no. 5, pp. 337–342, 2013.
- M. E. Yue, T. F. Jiang, and Y. P. Shi, “Simultaneous determination of noradrenaline and dopamine in Portulaca oleracea L. by capillary zone electrophoresis,” Journal of Separation Science, vol. 28, no. 4, pp. 360–364, 2005.
- L. Xiang, D. Xing, W. Wang, R. Wang, Y. Ding, and L. Du, “Alkaloids from Portulaca oleracea L.,” Phytochemistry, vol. 66, no. 21, pp. 2595–2601, 2005.
- J. L. Tian, X. Liang, P. Y. Gao et al., “Two new alkaloids from Portulaca oleracea and their cytotoxic activities,” Journal of Asian Natural Products Research, vol. 16, pp. 259–264, 2014.
- A. E. Abdel Moneim, “The neuroprotective effects of purslane (Portulaca oleracea) on rotenone-induced biochemicalchanges and apoptosis in brain of rat,” CNS & Neurological Disorders—Drug Targets, vol. 12, no. 6, pp. 830–841, 2013.
- A. P. Simopoulos, D. X. Tan, L. C. Manchester, and R. J. Reiter, “Purslane: a plant source of omega-3 fatty acids and melatonin,” Journal of Pineal Research, vol. 39, no. 3, pp. 331–332, 2005.
- H.-L. Xin, Y.-F. Xu, Y.-H. Hou et al., “Two novel triterpenoids from Portulaca oleracea L.,” Helvetica Chimica Acta, vol. 91, no. 11, pp. 2075–2080, 2008.
- M. K. Uddin, A. S. Juraimi, M. S. Hossain, M. A. U. Nahar, M. E. Ali, and M. M. Rahman, “Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes,” The Scientific World Journal, vol. 2014, Article ID 951019, 6 pages, 2014.
- W. Wang, L. Gu, L. Dong, X. Wang, C. Ling, and M. Li, “Protective effect of Portulaca oleracea extracts on hypoxic nerve tissue and its mechanism,” Asia Pacific Journal of Clinical Nutrition, vol. 16, supplement 1, pp. 227–233, 2007.
- W. Wang, L. Dong, L. Jia, H. Xin, C. Ling, and M. Li, “Ethanol extract of Portulaca oleracea L. protects against hypoxia-induced neuro damage through modulating endogenous erythropoietin expression,” The Journal of Nutritional Biochemistry, vol. 23, no. 4, pp. 385–391, 2012.
- C.-Q. Wang and G.-Q. Yang, “Betacyanins from Portulaca oleracea L. ameliorate cognition deficits and attenuate oxidative damage induced by D-galactose in the brains of senescent mice,” Phytomedicine, vol. 17, no. 7, pp. 527–532, 2010.
- Z. Yang, D. Zhang, J. Ren, M. Yang, and S. Li, “Acetylcholinesterase inhibitory activity of the total alkaloid from traditional Chinese herbal medicine for treating Alzheimer's disease,” Medicinal Chemistry Research, vol. 21, no. 6, pp. 734–738, 2012.
- L. Shen and F. E. Lu, “Effects of Portulaca oleracea on insulin resistance in rats with type 2 diabetes mellitus,” Chinese Journal of Integrative Medicine, vol. 9, no. 4, pp. 289–292, 2003.
- M.-I. K. El-Sayed, “Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 643–651, 2011.
- A. S. Lee, Y. J. Lee, S. M. Lee et al., “Portulaca oleracea ameliorates diabetic vascular inflammation and endothelial dysfunction in db/db mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 741824, 9 pages, 2012.
- F. Gong, F. Li, L. Zhang, J. Li, Z. Zhang, and G. Wang, “Hypoglycemic effects of crude polysaccharide from Purslane,” International Journal of Molecular Sciences, vol. 10, no. 3, pp. 880–888, 2009.
- J. Behravan, F. Mosafa, N. Soudmand, E. Taghiabadi, B. M. Razavi, and G. Karimi, “Protective effects of aqueous and ethanolic extracts of Portulaca oleracea L. aerial parts on H2O2-induced DNA damage in lymphocytes by comet assay,” Journal of Acupuncture and Meridian Studies, vol. 4, no. 3, pp. 193–197, 2011.
- G. Karimi, M. Aghasizadeh, M. Razavi, and E. Taghiabadi, “Protective effects of aqueous and ethanolic extracts of Nigella sativa L. and Portulaca oleracea L. on free radical induced hemolysis of RBCs,” DARU, Journal of Pharmaceutical Sciences, vol. 19, no. 4, pp. 295–300, 2011.
- Y. Liu, C. Liu, H. Tan, T. Zhao, J. Cao, and F. Wang, “Sulfation of a polysaccharide obtained from Phellinus ribis and potential biological activities of the sulfated derivatives,” Carbohydrate Polymers, vol. 77, no. 2, pp. 370–375, 2009.
- J. Zhu and M. Wu, “Characterization and free radical scavenging activity of rapeseed meal polysaccharides WPS-1 and APS-2,” Journal of Agricultural and Food Chemistry, vol. 57, no. 3, pp. 812–819, 2009.
- G. Tommonaro, C. S. Segura Rodríguez, M. Santillana et al., “Chemical composition and biotechnological properties of a polysaccharide from the peels and antioxidative content from the pulp of Passiflora liguralis fruits,” Journal of Agricultural and Food Chemistry, vol. 55, no. 18, pp. 7427–7433, 2007.
- X. B. Yang, Y. Zhao, Y. Yang, and Y. Ruan, “Isolation and characterization of immunostimulatory polysaccharide from an herb tea, Gynostemma pentaphyllum makino,” Journal of Agricultural and Food Chemistry, vol. 56, no. 16, pp. 6905–6909, 2008.
- Y. G. Chen, Z. J. Shen, and X. P. Chen, “Evaluation of free radicals scavenging and immunity-modulatory activities of Purslane polysaccharides,” International Journal of Biological Macromolecules, vol. 45, no. 5, pp. 448–452, 2009.
- T. Chen, J. Wang, Y. Li, J. Shen, T. Zhao, and H. Zhang, “Sulfated modification and cytotoxicity of Portulaca oleracea L. polysaccharides,” Glycoconjugate Journal, vol. 27, no. 6, pp. 635–642, 2010.
- G.-Y. Zheng, L.-P. Qu, X.-Q. Yue, W. Gu, H. Zhang, and H.-L. Xin, “Portulacerebroside A induces apoptosis via activation of the mitochondrial death pathway in human liver cancer HCCLM3 cells,” Phytochemistry Letters, vol. 7, no. 1, pp. 77–84, 2014.
- K.-B. Oh, I.-M. Chang, K.-J. Hwang, and W. Mar, “Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system,” Phytotherapy Research, vol. 14, no. 5, pp. 329–332, 2000.
- C.-X. Dong, K. Hayashi, J.-B. Lee, and T. Hayashi, “Characterization of structures and antiviral effects of polysaccharides from Portulaca oleracea L.,” Chemical & Pharmaceutical Bulletin (Tokyo), vol. 58, no. 4, pp. 507–510, 2010.
- A. S. Lee, J. S. Kim, Y. J. Lee, D. G. Kang, and H. S. Lee, “Anti-TNF-α activity of Portulaca oleracea in vascular endothelial cells,” International Journal of Molecular Sciences, vol. 13, no. 12, pp. 5628–5644, 2012.
- D. Prabha, S. Sivakumar, C. V. Subbhuraam, and H. K. Son, “Responses of Portulaca oleracea Linn. to selenium exposure,” Toxicology and Industrial Health, 2013.
- J. Chen, Y.-P. Shi, and J.-Y. Liu, “Determination of noradrenaline and dopamine in Chinese herbal extracts from Portulaca oleracea L. by high-performance liquid chromatography,” Journal of Chromatography A, vol. 1003, no. 1-2, pp. 127–132, 2003.
- X. Liang, J. Tian, L. Li et al., “Rapid determination of eight bioactive alkaloids in Portulaca oleracea L. by the optimal microwave extraction combined with positive-negative conversion multiple reaction monitor (+/−MRM) technology,” Talanta, vol. 120, pp. 167–172, 2014.
- K. H. Aljeboori, O. H. Rubai, O. H. Nahi, and N. Y. Yassen, “Study of pathological, effects of crude extract of Portulaca olercea L. in the albino mice organs,” International Journal of Technical Research and Applications, vol. 2, no. 1, pp. 29–32, 2014.
- N. Sakai, K. Inada, M. Okamoto, Y. Shizuri, and Y. Fukuyama, “Portuloside A, a monoterpene glucoside, from Portulaca oleracea,” Phytochemistry, vol. 42, no. 6, pp. 1625–1628, 1996.
- Y. Seo, J. Shin, H. J. Cha et al., “A new monoterpene glucoside from Portulaca oleracea,” Bulletin of the Korean Chemical Society, vol. 24, no. 10, pp. 1475–1477, 2003.
- D. Esiyok, S. Ötles, and E. Akcicek, “Herbs as a food source in Turkey,” Asian Pacific Journal of Cancer Prevention, vol. 5, no. 3, pp. 334–339, 2004.
- Z. Yang, C. Liu, L. Xiang, and Y. Zheng, “Phenolic alkaloids as a new class of antioxidants in Portulaca oleracea,” Phytotherapy Research, vol. 23, no. 7, pp. 1032–1035, 2009.
- Z. Cheng, D. Wang, W. Zhang et al., “LC determination and pharmacokinetic study of the main phenolic components of Portulaca oleracea L. extract in rat plasma after oral administration,” Natural Product Research: Formerly Natural Product Letters, vol. 26, no. 23, pp. 2247–2250, 2012.
- H.-L. Xin, Y.-H. Hou, Y.-F. Xu et al., “Portulacerebroside A: new cerebroside from Portulaca oleracea L.,” Chinese Journal of Natural Medicines, vol. 6, no. 6, pp. 401–403, 2008.
- I. Yazici, I. Türkan, A. H. Sekmen, and T. Demiral, “Salinity tolerance of purslane (Portulaca oleracea L.) is achieved by enhanced antioxidative system, lower level of lipid peroxidation and proline accumulation,” Environmental and Experimental Botany, vol. 61, no. 1, pp. 49–57, 2007.
- G. E. Wenzel, J. D. Fontana, and J. B. C. Correa, “The viscous mucilage from the weed Portulaca oleracea L.,” Applied Biochemistry and Biotechnology, vol. 24-25, pp. 341–353, 1990.
Copyright © 2015 Yan-Xi Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.